Manalo, Baby Girl .

HRN: 24-76-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/04/2024
06/10/2024
IVTT
100mg
Q24h
Pcap C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: